Cell Cycle Regulation and Adult T Cell Leukemia
细胞周期调节和成人 T 细胞白血病
基本信息
- 批准号:7866744
- 负责人:
- 金额:$ 31.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2015-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAffectAnaphaseAneuploidyBiologicalCD4 Positive T LymphocytesCell AgingCell CycleCell Cycle RegulationCell LineCell ProliferationCellsChromosomal InstabilityCyclin ACyclin BCyclin EDNADNA DamageDNA biosynthesisDevelopmentDown-RegulationEtiologyG2 PhaseHTLV-1 InfectionHela CellsHumanHuman T-lymphotropic virus 1IndividualLeadLicensing FactorMalignant NeoplasmsMediatingMessenger RNAMetaphaseMitoticMolecularNuclearOncogene ProteinsParalysedPathway interactionsPhosphorylationProteinsRas/RafReplication LicensingRoleSignal PathwaySpinal Cord DiseasesT-Cell LeukemiaT-Cell TransformationT-LymphocyteTaxesTestingTimeTrans-ActivatorsTropical Spastic ParaparesisUbiquitinationUp-RegulationViralVirusanaphase-promoting complexcell transformationhuman PTTG1 proteininhibitor/antagonistinsightleukemialeukemia/lymphomanervous system disorderosteosarcomaprematurepreventpromoterpublic health relevancesenescencetreatment strategyubiquitin-protein ligase
项目摘要
DESCRIPTION (provided by applicant): HTLV-I is the causative agent of adult T-cell leukemia/lymphoma (ATL), a malignancy of CD4+ T cells whose etiology is associated with the viral transactivator/oncoprotein, Tax. We have shown that Tax can activate the anaphase promoting complex/cyclosome (APC/C), an E3 ubiquitin ligase that controls metaphase to anaphase transition and mitotic exit. APC/C activation by Tax leads to the premature poly-ubiquitination and degradation of mitotic regulators including cyclin A, cyclin B, securin, and Skp2. Skp2 is the substrate-targeting subunit of another E3 ubiquitin ligase known as SCFSkp2, which mediates the destruction of cyclin E/A-CDK2 inhibitor (CKI), p27. The degradation of Skp2 by APC/C as induced by Tax leads to SCFSkp2 inactivation and p27 stabilization. The mRNA level of another CKI, p21, also increases sharply as a result of promoter activation and mRNA stabilization by Tax. The great surge in p21 and p27 in turn induces cellular senescence termed Tax-induced rapid senescence (Tax-IRS). As expected, HeLa and SupT1 T cells infected by HTLV-1 arrest in senescence as well. By contrast, cells deficient in p21 and p27, such as HOS, escape Tax-IRS and continue to divide after HTLV-1 infection or Tax expression. They, however, develop dramatic nuclear abnormalities in the form of multinucleation and DNA aneuploidy. Importantly, down-regulation of p27 and mis-localization of p21 are common in Tax-expressing HTLV-1-transformed T (HTxT) cells and most likely occur through activation of the PI3K- Akt pathway. Our latest results showed that Tax caused significant accumulation of the DNA replication licensing factor, Cdt1, during S/G2. In a most exciting recent development, we found that inhibition of NF-?B activation by Tax completely abrogated Tax-IRS. Our findings raise several important questions: How does persistent NF-?B activation lead to p21/p27 upregulation and senescence? Does NF-?B activation lie upstream of APC/C activation and Cdt1 accumulation? Does the accumulation of Cdt1 induced by Tax lead to DNA re/hyper-replication and can it explain the dramatic nuclear abnormalities seen in Tax-expressing cells? Finally, the senescence-like arrest induced by HTLV-1 in SupT1 and HeLa cells suggests that primary T cells productively infected by HTLV-1 likely also undergo senescence. If so, then how does a virus that induces senescence cause leukemia? How do HTxT cell lines manage to adapt to Tax and continue to divide? To address these questions and to elucidate the pathway by which HTLV-1 infection leads to T cell transformation and ATL, three specific aims are proposed: (1) to delineate the pathway leading from persistent NF-?B activation by Tax to senescence; (2) to investigate the cause and biological effects of HTLV- and Tax-induced chromosome instability; and (3) to elucidate the mechanisms by which cells become adapted to (transformed by) Tax and HTLV-1.
PUBLIC HEALTH RELEVANCE: Human T-lymphotropic virus type I (HTLV-1) infects more than 20 million people world-wide. A significant percentage of infected individuals develop adult T-cell leukemia and a paralytic neurological disease known as HTLV-1-associated myelopathy/tropical spastic paraparesis. This project will elucidate the mechanism by which HTLV-1 infection affects the progression of cell division cycle and how these changes impact on the development of leukemia. The study will provide molecular insights that can lead to the development of treatment strategies for human cancer
描述(由申请方提供):HTLV-I是成人T细胞白血病/淋巴瘤(ATL)的病原体,ATL是一种CD 4 + T细胞恶性肿瘤,其病因与病毒反式激活因子/癌蛋白Tax相关。我们已经表明,税收可以激活后期促进复合物/细胞周期体(APC/C),E3泛素连接酶,控制中期到后期的过渡和有丝分裂退出。Tax激活APC/C导致包括细胞周期蛋白A、细胞周期蛋白B、securin和Skp 2在内的有丝分裂调节因子的过早多聚泛素化和降解。Skp 2是另一种称为SCFSkp 2的E3泛素连接酶的底物靶向亚基,其介导细胞周期蛋白E/A-CDK 2抑制剂(CKI)p27的破坏。Tax诱导的APC/C对Skp 2的降解导致SCFSkp 2失活和p27稳定。另一种CKI p21的mRNA水平也由于Tax的启动子激活和mRNA稳定而急剧增加。p21和p27的激增反过来诱导细胞衰老,称为Tax-induced rapid senescence(Tax-IRS)。正如预期的那样,被HTLV-1感染的HeLa和SupT 1 T细胞也在衰老中停滞。相比之下,缺乏p21和p27的细胞,如HOS,在HTLV-1感染或Tax表达后逃避Tax-IRS并继续分裂。然而,它们以多核化和DNA非整倍体的形式发展出显著的核异常。重要的是,p27的下调和p21的错误定位在Tax表达HTLV-1转化的T(HTxT)细胞中是常见的,并且最有可能通过PI 3 K-Akt途径的激活而发生。我们的最新研究结果表明,税收引起的DNA复制许可因子,Cdt 1,在S/G2的显着积累。在一个最令人兴奋的最近的发展,我们发现,抑制NF-?通过税务激活B完全废除了Tax-IRS。我们的研究结果提出了几个重要的问题:如何持续NF-?B激活导致p21/p27上调和衰老?NF-?B激活位于APC/C激活和Cdt 1积累的上游。Tax诱导的Cdt 1的积累是否会导致DNA再复制/超复制,它能否解释Tax表达细胞中观察到的显著核异常?最后,在SupT 1和HeLa细胞中由HTLV-1诱导的衰老样停滞表明,由HTLV-1有效感染的原代T细胞也可能经历衰老。如果是这样,那么一种诱导衰老的病毒是如何导致白血病的呢?HTxT细胞系如何适应Tax并继续分裂?为了解决这些问题,并阐明HTLV-1感染导致T细胞转化和ATL的途径,提出了三个具体目标:(1)描绘从持续NF-?Tax诱导的B活化至衰老;(2)研究HTLV和Tax诱导的染色体不稳定性的原因和生物学效应;(3)阐明细胞适应Tax和HTLV-1(被Tax和HTLV-1转化)的机制。
人类嗜T淋巴细胞病毒I型(HTLV-1)在全世界感染了2000多万人。相当比例的感染个体发展成成人T细胞白血病和称为HTLV-1相关性脊髓病/热带痉挛性下肢轻瘫的麻痹性神经系统疾病。该项目将阐明HTLV-1感染影响细胞分裂周期进展的机制以及这些变化如何影响白血病的发展。该研究将提供分子见解,可以导致人类癌症治疗策略的发展
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHOU-ZEN GIAM其他文献
CHOU-ZEN GIAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHOU-ZEN GIAM', 18)}}的其他基金
HTLV-1 Replication/Reactivation-Induced DNA Damage: Mechanisms and Pathogenesis
HTLV-1 复制/重新激活诱导的 DNA 损伤:机制和发病机制
- 批准号:
10572907 - 财政年份:2022
- 资助金额:
$ 31.09万 - 项目类别:
Cell Cycle Regulation and Adult T Cell Leukemia
细胞周期调节和成人 T 细胞白血病
- 批准号:
8052727 - 财政年份:2010
- 资助金额:
$ 31.09万 - 项目类别:
Cell Cycle Regulation and Adult T Cell Leukemia
细胞周期调节和成人 T 细胞白血病
- 批准号:
8607791 - 财政年份:2010
- 资助金额:
$ 31.09万 - 项目类别:
Cell Cycle Regulation and Adult T Cell Leukemia
细胞周期调节和成人 T 细胞白血病
- 批准号:
8396677 - 财政年份:2010
- 资助金额:
$ 31.09万 - 项目类别:
Cell Cycle Regulation and Adult T Cell Leukemia
细胞周期调节和成人 T 细胞白血病
- 批准号:
8448784 - 财政年份:2010
- 资助金额:
$ 31.09万 - 项目类别:
Cell Cycle Regulation and Adult T Cell Leukemia
细胞周期调节和成人 T 细胞白血病
- 批准号:
8265753 - 财政年份:2010
- 资助金额:
$ 31.09万 - 项目类别:
Cell Cycle Regulation and Adult T Cell Leukemia
细胞周期调节和成人 T 细胞白血病
- 批准号:
8214695 - 财政年份:2010
- 资助金额:
$ 31.09万 - 项目类别:
Cell Cycle Regulation and Adult T Cell Leukemia
细胞周期调节和成人 T 细胞白血病
- 批准号:
8791965 - 财政年份:2010
- 资助金额:
$ 31.09万 - 项目类别:
Cell Cycle Regulation and Adult T Cell Leukemia
细胞周期调节和成人 T 细胞白血病
- 批准号:
8607461 - 财政年份:2010
- 资助金额:
$ 31.09万 - 项目类别:
Carl Zeiss LSM 510 Confocal Inverted Microscope System
Carl Zeiss LSM 510 共焦倒置显微镜系统
- 批准号:
7389697 - 财政年份:2008
- 资助金额:
$ 31.09万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 31.09万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 31.09万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 31.09万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 31.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 31.09万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 31.09万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 31.09万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 31.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 31.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 31.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)